000			01833nam a2200397 i 4500
999			_c282167 _d282167
001			on1097555090
003			OCoLC
005			20190628155319.0
008			190417s2019 dcu b f000 0 eng c
040			_aPUCPR _beng _erda _cGPO _dMvI
042			_apcc
043			_an-us---
074			_a1028-A
086	0		_aY 4.W 36:115-OS 01
088			_aSerial no. 115-OS01 (United States. Congress. House. Committee on Ways and Means)
099			_aY 4.W 36:115-OS 01
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Ways and Means. _bSubcommittee on Oversight,
245	1	0	_aExamining the effectiveness of the individual mandate under the Affordable Care Act : _bhearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Fifteenth Congress, first session, January 24, 2017.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2019.
300			_aiii, 63 pages ; _c24 cm
336			_btxt
337			_bn _2rdamedia
338			_bnc _2rdacarrier
500			_aShipping list no.: 2019-0198-P.
500			_a"Serial no. 115-OS01."
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
776	0	8	_iOnline version: _aUnited States. Congress. House. Committee on Ways and Means. Subcommittee on Oversight. _tExamining the effectiveness of the individual mandate under the Affordable Care Act _w(OCoLC)1090652665
050		4	_aKF27 _b.W345 2017c
610	1	0	_aUnited States. _tPatient Protection and Affordable Care Act.
650		0	_aCompulsory health insurance _zUnited States.
650		0	_aMedical care _zUnited States _xCost control.
650		0	_aHealth insurance _zUnited States _xCosts.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8